Busch Matthew C. 4

What Happened Matthew C. Busch, Vice President, Finance & Chief Accounting Officer of Amgen Inc. (AMGN), sold 1,000 shares of Amgen common stock in an open-market transaction on February 19, 2026. The shares were sold at $375.79 per share for gross proceeds of $375,790. This was a sale (not a purchase or exercise) and thus is typically considered routine insider selling rather than an explicit positive signal.

Key Details

• Transaction date and price: 2026-02-19 — 1,000 shares sold at $375.79 per share (total $375,790).
• Filing date / timeliness: Form 4 filed 2026-02-20 for the 2026-02-19 transaction (filed the next day).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The filing notes 60 Dividend Equivalents (DEs) are included; DEs are credited to unvested RSUs and are paid in shares on a one-to-one basis per the vesting schedule, with cash for any fractional share.

Context This was an open-market sale (code S). Sales by officers can be routine (cash needs, diversification, tax obligations, or portfolio rebalancing) and do not by themselves indicate a change in company outlook. No option exercises, gifts, or tax-withholding events were reported in this transaction.